These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9274002

  • 1. Semisynthetic glycopeptides: chemistry, structure-activity relationships and prospects.
    Ciabatti R, Malabarba A.
    Farmaco; 1997 May; 52(5):313-21. PubMed ID: 9274002
    [Abstract] [Full Text] [Related]

  • 2. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN.
    J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030
    [Abstract] [Full Text] [Related]

  • 3. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
    He H.
    Appl Microbiol Biotechnol; 2005 Jun 27; 67(4):444-52. PubMed ID: 15702316
    [Abstract] [Full Text] [Related]

  • 4. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
    Olsuf'eva EN, Preobrazhenskaia MN.
    Bioorg Khim; 2006 Jun 27; 32(4):339-59. PubMed ID: 16909859
    [Abstract] [Full Text] [Related]

  • 5. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR, Wheeler C, Ip E, Plattner JJ, Chu D, Zhang YK, Preobrazhenskaya MN, Printsevskaya SS, Solovieva SE, Olsufyeva EN, Heine H, Lovchik J, Lyons CR.
    J Med Chem; 2007 Jul 26; 50(15):3681-5. PubMed ID: 17608397
    [Abstract] [Full Text] [Related]

  • 6. Glycopeptides: Update on an old successful antibiotic class.
    Pace JL, Yang G.
    Biochem Pharmacol; 2006 Mar 30; 71(7):968-80. PubMed ID: 16412985
    [Abstract] [Full Text] [Related]

  • 7. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan.
    Beltrametti F, Consolandi A, Carrano L, Bagatin F, Rossi R, Leoni L, Zennaro E, Selva E, Marinelli F.
    Antimicrob Agents Chemother; 2007 Apr 30; 51(4):1135-41. PubMed ID: 17220405
    [Abstract] [Full Text] [Related]

  • 8. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu, Olsuf'eva EN, Miroshnikova OV, Reznikova MI, Lazhko EI, Malabarba A, Ciabatti R, Preobrazhenskaia MN.
    Bioorg Khim; 1997 May 30; 23(5):410-21. PubMed ID: 9290051
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
    Arhin FF, Belley A, McKay GA, Moeck G.
    Curr Protoc Microbiol; 2010 Feb 30; Chapter 17():Unit17.1. PubMed ID: 20131224
    [Abstract] [Full Text] [Related]

  • 10. A multivalent approach to drug discovery for novel antibiotics.
    Long DD, Aggen JB, Christensen BG, Judice JK, Hegde SS, Kaniga K, Krause KM, Linsell MS, Moran EJ, Pace JL.
    J Antibiot (Tokyo); 2008 Oct 30; 61(10):595-602. PubMed ID: 19168973
    [Abstract] [Full Text] [Related]

  • 11. Origin, structure, and activity in vitro and in vivo of dalbavancin.
    Malabarba A, Goldstein BP.
    J Antimicrob Chemother; 2005 Mar 30; 55 Suppl 2():ii15-20. PubMed ID: 15750032
    [Abstract] [Full Text] [Related]

  • 12. [Glycopeptide antibiotics resistance mechanism as the basis for novel derivatives development capable to overcome resistance].
    Trenin AS, Olsuf'eva EN.
    Bioorg Khim; 1997 Nov 30; 23(11):851-67. PubMed ID: 9518425
    [Abstract] [Full Text] [Related]

  • 13. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu, Preobrazhenskaia MN.
    Bioorg Khim; 1998 Sep 30; 24(9):644-62. PubMed ID: 9813730
    [Abstract] [Full Text] [Related]

  • 14. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R, Szulc M, Madaj J.
    Carbohydr Res; 2014 May 07; 389():154-64. PubMed ID: 24685455
    [Abstract] [Full Text] [Related]

  • 15. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B, Sarkar C, Biswas R, Pandey S.
    Pak J Pharm Sci; 2008 Jan 07; 21(1):78-87. PubMed ID: 18166524
    [Abstract] [Full Text] [Related]

  • 16. [Microbiological-clinical study on the efficacy of a new antibiotic: teicoplanin].
    Martinetto P, Gariglio M, Malcangi A, Cavallo GP.
    G Batteriol Virol Immunol; 1985 Jan 07; 78(1-6):86-94. PubMed ID: 2943627
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
    Gales AC, Sader HS, Jones RN.
    Clin Microbiol Infect; 2005 Feb 07; 11(2):95-100. PubMed ID: 15679482
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS, Reznikova MI, Korolev AM, Lapa GB, Olsufyeva EN, Preobrazhenskaya MN, Plattner JJ, Zhang YK.
    Future Med Chem; 2013 Apr 07; 5(6):641-52. PubMed ID: 23617428
    [Abstract] [Full Text] [Related]

  • 19. Microbiological properties of teicoplanin.
    Greenwood D.
    J Antimicrob Chemother; 1988 Jan 07; 21 Suppl A():1-13. PubMed ID: 2965119
    [Abstract] [Full Text] [Related]

  • 20. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C, Chen L, Barrett D, Panzone G, Sun B, Falcone B, Oberthür M, Donadio S, Walker S, Kahne D.
    J Am Chem Soc; 2005 Mar 16; 127(10):3250-1. PubMed ID: 15755121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.